Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 8/20 | 0.59 |
| ▸ | PNP | P00491 | 4/20 | 0.55 |
| ▸ | TK1 | P04183 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | EDNRA | P25101 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | HBB | P68871 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | VCP | P55072 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28095386 | 0.84 | XDH (0.57) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL986800 | 0.84 | XDH (0.60) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL15005119 | 0.82 | XDH (0.59) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL27667185 | 0.82 | XDH (0.63) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL24499589 | 0.81 | XDH (0.40) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL2051364 | 0.81 | XDH (0.57) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL10835122 | 0.81 | XDH (0.61) | XDHPNPTK1BLMUSP2 | |
| 9-Methylguanine SCHEMBL22884 | 0.81 | XDH (0.58) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL22533906 | 0.81 | XDH (0.57) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL24236963 | 0.81 | HPGD (0.46) | XDHPNPTK1BLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286631-A | Water phase preparation method and application of guanine twin crystal nanosheet | 北京理工大学 | 2022-11-04 | — | — | CN | claimed |
| CN-101784556-B | Thiocarbon-protecting groups for rna synthesis | AGILENT TECHNOLOGIES INC | 2014-07-09 | — | — | CN | claimed |
| CN-103476947-A | Enhanced biodistribution of oligomers | GROOVE BIOPHARMA CORP | 2013-12-25 | — | — | CN | claimed |
| CN-103068834-A | Phosphoramidites for reverse RNA synthesis | CHEMGENES CORP | 2013-04-24 | — | — | CN | claimed |
| CN-102766182-A | Method for synthesizing dideoxynucleoside through glycosyl transfer reaction and application thereof | JIANGYIN SULI CHEMICAL CO LTD | 2012-11-07 | — | — | CN | claimed |
| US-8039611-B2 | 2′-hydroxyl group-modified ribonucleoside derivatives | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-10-18 | — | — | US | claimed |
| CN-1189562-C | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | GENESENSE TECHNOLOGIES INC (CA) | 2005-02-16 | — | — | CN | claimed |
| CN-1160402-A | Purine and guanine compounds as inhibitors of PNP | CHIROSCIENCE LTD (GB) | 1997-09-24 | — | — | CN | claimed |
| EP-4698674-A1 | METHODS TO TREAT GLIOMA IN SUBJECTS WITH DEFINED TUMOUR MICROENVIRONMENT | University Health Network (CA) | 2026-02-25 | — | — | EP | disclosed |
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | UNIV GUELPH (CA) | 2026-02-19 | — | — | US | disclosed |
| EP-4615994-A1 | DNAZYME FOR EOSINOPHIL PEROXIDASE AND USES THEREOF | McMaster University (CA) | 2025-09-17 | — | — | EP | disclosed |
| WO-2025085704-A1 | BRAIN-CELL SPECIFIC PARTIAL CELLULAR REPROGRAMMING TREATMENT AND PREVENTION METHODS FOR ALZHEIMER'S DISEASE AND PROGERIA, COMPOSITIONS THEREFORE, AND USES THEREOF | YOUTHBIO THERAPEUTICS INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| WO-2024250102-A1 | FOOD PACKAGING SYSTEM FOR DETECTING PATHOGENIC BACTERIA | TOYOTA TSUSHO CANADA, INC. (CA) | 2024-12-12 | — | — | WO | disclosed |
| US-20240392343-A1 | METHODS TO SCREEN YEAST TO IDENTIFY XENOBIOTICS THAT TARGET PESTS, PATHOGENS AND PARASITES | ROY PETER J (CA) | 2024-11-28 | — | — | US | disclosed |
| EP-0604409-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0549615-A1 | SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| WO-1992003568-A1 | SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1992-03-05 | — | — | WO | disclosed |
| WO-1991010671-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1991-07-25 | — | — | WO | disclosed |
| CN-1036578-A | NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES | MERRELL DOW PHARMA (US) | 1989-10-25 | — | — | CN | disclosed |
| EP-0310365-A1 | Engine seal compatible dispersant for lubricating oils | AMOCO CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | DPP3, IDE, NOTCH3 | XDH 4554/4885PNP 1073/4885TK1 1490/4885 |
| US-20240392343-A1 | METHODS TO SCREEN YEAST TO IDENTIFY XENOBIOTICS THAT TARGET PESTS, PATHOGENS AND PARASITES | CYP4X1, CYP7A1, CYP1A1 | XDH 56/4885PNP 460/4885TK1 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.